Cargando…
High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
MicroRNA-454 (miR-454) has been reported to play an oncogenic or tumor suppressor role in most cancers. However, the clinical relevance of miR-454 in breast cancer remains unclear. We examined the expression of miR-454 in a tissue microarray containing 534 breast cancer specimens from female patient...
Autores principales: | Cao, Zhi-Gang, Li, Jun-Jing, Yao, Ling, Huang, Yan-Ni, Liu, Yi-Rong, Hu, Xin, Song, Chuan-Gui, Shao, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323124/ https://www.ncbi.nlm.nih.gov/pubmed/27588500 http://dx.doi.org/10.18632/oncotarget.11764 |
Ejemplares similares
-
ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression
por: Li, Kai, et al.
Publicado: (2014) -
MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
por: Li, Qun, et al.
Publicado: (2017) -
MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018) -
Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
por: Zeng, Zhihao, et al.
Publicado: (2017) -
High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer
por: Chen, Li, et al.
Publicado: (2015)